Literature DB >> 438530

Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis.

F P Tally, D R Snydman, S L Gorbach, M H Malamy.   

Abstract

A clindamycin- and erythromycin-resistant strain of Bacteroides fragilis, TMP10, that had been isolated from a blood culture transferred its drug resistance in a Millipore mating procedure to another strain of B. fragilis, TM2000, and to a strain of Bacteroides thetaiotaomicron. Donor strain TMP10 contained numerous species of extrachromosomal DNA ranging from approximately 2 x 10(6) to 20 x 10(6) daltons in molecular weight, as revealed by agarose gel electrophoresis. Clindamycin- and erythromycin-resistant transcipient cells of B. fragilis strain TM2000 always contained at least two plasmid species with molecular weights of 2 x 10(6) and 20 x 10(6) daltons, respectively, although other plasmid species were also transferred.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 438530     DOI: 10.1093/infdis/139.1.83

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment.

Authors:  K Tunér; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

2.  Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.

Authors:  D R Snydman; N V Jacobus; L A McDermott; S Supran; G J Cuchural; S Finegold; L Harrell; D W Hecht; P Iannini; S Jenkins; C Pierson; J Rihs; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

3.  Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus beta-lactamase II.

Authors:  J S Thompson; M H Malamy
Journal:  J Bacteriol       Date:  1990-05       Impact factor: 3.490

4.  Isolation and purification of plasmids from Bacteroides fragilis using rubidium trichloroacetate density gradient centrifugation.

Authors:  E J Zöllner; C von Eichel-Streiber; F P Schwindling
Journal:  Mol Gen Genet       Date:  1983

5.  Tetracycline-inducible transfer of tetracycline resistance in Bacteroides fragilis in the absence of detectable plasmid DNA.

Authors:  A Rashtchian; G R Dubes; S J Booth
Journal:  J Bacteriol       Date:  1982-04       Impact factor: 3.490

6.  Hybridization studies reveal homologies between pBF4 and pBFTM10, Two clindamycin-erythromycin resistance transfer plasmids of Bacteroides fragilis.

Authors:  M J Shimell; C J Smith; F P Tally; F L Macrina; M H Malamy
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

7.  Plasmid analyses in clinical isolates of Bacteroides fragilis and other Bacteroides species.

Authors:  B L Wallace; J E Bradley; M Rogolsky
Journal:  J Clin Microbiol       Date:  1981-10       Impact factor: 5.948

8.  Belgian Collaborative Study of the in-vitro susceptibility of the Bacteroides fragilis group. A Belgian Collaborative Study Group.

Authors: 
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

9.  Large transmissible clindamycin resistance plasmid in Bacteroides ovatus.

Authors:  C J Smith; F L Macrina
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

10.  Novel antibiotic resistance transfer in Bacteroides.

Authors:  T D Mays; C J Smith; R A Welch; C Delfini; F L Macrina
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.